Clik here to view.
Dr. Reddy’s Laboratories Receives Approval for Aspirin and Extended-Release...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced receipt...
View ArticleClik here to view.
HiFiBiO Therapeutics Acquires H-Immune Therapeutics
CAMBRIDGE, Mass. & PARIS & SHANGHAI HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the...
View ArticleClik here to view.
Clik here to view.
Sinovac Commences Legal Proceedings to Nullify Filings Bearing a Falsified...
BEIJING Senior management of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) and the lawful directors of Sinovac Hong Kong have commenced legal proceedings in the High Court of the...
View ArticleClik here to view.
Chan Zuckerberg Biohub and Chan Zuckerberg Initiative Announce...
BERLIN Today the Chan Zuckerberg Biohub (Biohub) and the Chan Zuckerberg Initiative (CZI) unveiled the soft-launch of IDseq, an open source cloud-based analysis platform that has the potential to...
View ArticleClik here to view.
Biogen and Samsung Bioepis Announce European Launch of IMRALDI™(adalimumab),...
CAMBRIDGE, Mass. & INCHEON, Korea Biogen (Nasdaq:BIIB) and Samsung Bioepis Co., Ltd. today announced the European launch of IMRALDI™ (adalimumab), a biosimilar referencing HUMIRA®. Starting...
View ArticleClik here to view.
Foundation Medicine Announces Strategic Collaboration with Major...
CAMBRIDGE, Mass. Foundation Medicine, Inc. today announced a strategic collaboration with Novartis allowing the development of companion diagnostic (CDx) tests for the Novartis portfolio of targeted...
View ArticleClik here to view.
AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has received the first commercial sales orders...
View ArticleClik here to view.
Takeda Receives Clearance from the Japan Fair Trade Commission for the...
OSAKA, Japan NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH...
View ArticleClik here to view.
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib...
View ArticleClik here to view.
Investigational Subcutaneous Formulation of Vedolizumab Achieves and...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational...
View ArticleClik here to view.
James Till教授因干细胞发现而荣获2018年度江户川Niche奖
东京 (美国商业资讯) — 江户川Niche奖(The Edogawa Niche Prize)由日印再生医学中心(NCRM)与日本东京江户川病院联合设立，2018年度该奖项授予加拿大多伦多大学名誉教授James Till，以表彰他在20世纪60年代与Ernest McCulloch教授合作发现了干细胞(www.edogawanicheprize.org)。...
View ArticleClik here to view.
武田拟收购Shire plc获得日本公平交易委员会批准
日本大阪 (美国商业资讯)–如在任何司法管辖区内直接或间接发布、出版或分发全部或部分内容构成违反该司法管辖区有关法律的行为，则不得在此等司法管辖区实施该行为。 武田药品工业株式会社（Takeda Pharmaceutical Company Limited，“武田”）宣布其在2018年5月8日公布拟收购Shire plc的交易（“收购”）已获得日本公平交易委员会无条件批准。...
View ArticleClik here to view.
武田薬品工業によるシャイアーの買収案を日本の公正取引委員会が承認
大阪 （ビジネスワイヤ）– 本情報の全部または一部の直接的または間接的な公開、出版、配布が関係する法律の違反となる国・地域においては、そのような公開、出版、配布を禁止します。 武田薬品工業株式会社は、2018年5月8日に発表されたシャイアーplcの買収案（以下、「本買収」）について日本の公正取引委員会から無条件の承認を受領したと発表しました。...
View ArticleClik here to view.
2018年江戸川NICHE賞は幹細胞発見の功績によりジェームズ・ティル教授に授与へ
東京 （ビジネスワイヤ） — 日印再生医療センター（NCRM）と東京の江戸川病院が共同で創設した2018年江戸川NICHE賞は、1960年代にアーネスト・マコラック教授と共同で幹細胞を発見した功績により、トロント大学（カナダ）のジェームズ・ティル名誉教授に授与します（www.edogawanicheprize.org）。...
View ArticleClik here to view.
Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a...
BEIJING Senior management of Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”) and the lawful directors of Sinovac Hong Kong (“Lawful Directors”), Mr. Yin Weidong and Ms. Wang Nan, have...
View ArticleClik here to view.
武田呈报3期ALTA-1L试验结果，显示在晚期ALK+非小细胞肺癌一线治疗中，ALUNBRIG® (brigatinib)的颅内有效性优于克唑替尼
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE: 4502)今天宣布，3期ALTA-1L（ALK in Lung Cancer Trial of BrigAtinib in 1st...
View ArticleClik here to view.
CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership...
BEIJING & SHANGHAI CANbridge Pharmaceutical Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, and WuXi...
View ArticleClik here to view.
Morinaga Milk Study Suggests Infant-Type Human-Residential Bifidobacteria May...
TOKYO Scientists at Morinaga Milk Industry Co., Ltd. (TOKYO:2264) have long theorized that Human-Residential Bifidobacteria (HRB) are superior to non-Human-Residential Bifidobacteria (non-HRB) in...
View ArticleClik here to view.
Eminent Scientist James Till Turned Philanthropist; Donates Prize Money to...
TOKYO Stem cell discoverer Prof. James Till, Professor Emeritus, University of Toronto, Canada who was awarded the Edogawa Niche Prize 2018 (www.edogawanicheprize.org), jointly by Nichi-In Centre...
View Article